Pfizer Reports Strong Q4 2024 Results Amid Cost-Cutting Efforts On Tuesday, February, Pfizer announced its fourth-quarter earnings for 2024, surpassing market expectations, driven largely by strong sales of its COVID-19
-
13Mar2025